ophthalmic emulsion contains: Active: cyclosporine 0.05%. Inactives: glycerin; castor oil; polysorbate 80; carbomer copolymer type A; purified water; and sodium hydroxide to adjust pH. Cyclosporine is an immunosuppressive agent when administered systemically.

However, after Restasis therapy ceases, most patients will eventually experience a relapse of their symptoms. In general, patients are advised to use Restasis for a minimum of 6 months, with the understanding that the vast majority will require lifelong treatment to remain symptom-free.

Restasis has an average rating of 4.5 out of 10 from a total of 190 reviews for the treatment of Dry Eye Disease. 26% of reviewers reported a positive experience, while 50% reported a negative experience.

Cyclosporine eye drops are FDA approved for one use: chronic dry eye. This can also be called dry eye disease (DED) or keratoconjunctivitis sicca. This Restasis generic shares the same approved use as brand-name Restasis.

Restasis contains the active drug cyclosporine. It belongs to a class of drugs called calcineurin inhibitor immunosuppressants. Restasis is thought to work by calming down inflammation in your eyes and tear ducts.

No, Restasis is not a steroid eye drop. Restasis contains cyclosporine 0.05% ophthalmic, an eye drop used to treat chronic dry eye (also called keratoconjunctivitis sicca) that may be caused by inflammation. Restasis works by decreasing eye inflammation and increasing your tear production.

Restasis is approved to treat chronic dry eye. With this condition, there's inflammation or irritation in your eye that causes dryness. Restasis contains the active drug cyclosporine. It belongs to a class of drugs called calcineurin inhibitor immunosuppressants.

Treating your type of Chronic Dry Eye with RESTASIS® takes time and consistent use. Take one drop in each eye twice a day, every day, at least 12 hours apart. It may take 3 months for some patients to begin noticing an increase in tear production, with significant increase in tear production at 6 months.

In the largest study of more than 350 patients, 72% of participants were satisfied with the results after taking 0.05% cyclosporine ophthalmic emulsion for dry eye syndrome. Restasis works by decreasing swelling in the eye and increasing your eye's ability to produce tears.

Below is a quick summary of side effects you may experience while using Restasis.

• Burning sensation in the eye. The most common side effect people experience while using Restasis is a burning sensation.
• Red eye. Your eyes may become red while using Restasis.
• Foreign sensation in the eye.
• Watery eye.
• Eye pain.
• Blurry vision.

Restasis contains the active drug cyclosporine. It belongs to a class of drugs called calcineurin inhibitor immunosuppressants. Restasis is thought to work by calming down inflammation in your eyes and tear ducts.

RESTASIS® is available in two different forms: RESTASIS® single-use vials and RESTASIS MultiDose ® bottles. Choose the product type that's more convenient for you.